Drug
Edp 788
Edp 788: highest development phase Phase 1, developed by Enanta Pharmaceuticals. 2 trial records tracked on RxWires.
- Highest phase
- Phase 1
- Developer
- Enanta Pharmaceuticals
Trials
| Drug | Phase | Indication |
|---|---|---|
| EDP-788 NCT01999725 | Phase 1 | Safety in Normal Volunteers |
| EDP-788 NCT02255968 | Phase 1 | Healthy |
Latest
No recent events.
Follow Edp 788 on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.